ABSTRACT
Introduction
Bacterial infections remain the most harmful to human health [1] [2] . So, there is an urgent need for the development of new chemical entities more efficient than those currently available on the market and at the same time solving the problem of multi-drug resistance [3] [4] .Schiff bases, condensation products of primary amines with carbonyl compounds are considered as a very important class of organic compounds first reported by Hugo Schiff in 1864 [5] [6] . The common structural feature of these compounds is the azomethine group. Imine groups present in many natural compounds has been shown to be critical to their biological activities [7] [8] .Our systematic research on Schiff bases in general and diimines in particular allowed us to synthesize many compounds among which the series of compounds which is the subject of this study. From N,N'-bis (phenylmethylene)hexane-1,6-diamine, substitution of a nitro group on each aromatic ring and its systematic displacement in the positions ortho, meta and para led to have a homogeneous series of position isomers.Versatility of Schiff base ligands and important industrial applications of their complexes explain the numerous investigations carried out on these compounds. As part of our investigations on Schiff bases, we are interested in their biological activities. Indeed, Schiff bases have showed remarkable antiviral [9] , antimicrobial [10] , antifungal [11] , antitumors [12] , anticancer [13] [14] and antibacterial activities [15] [16] [17] .
The present paper deals with the synthesis, characterization and antimicrobial studies of all of the synthesized compounds shown in Figure1. 
Chemistry
Synthesis of title compounds was accomplished as outlined in figure 2 
Experimental protocols
All of the chemicals used in the syntheses were purchased from Sigma-Aldrich and were used as such. Thin layer chromatography was used to monitor the progress of the reactions. Melting points were determined in capillary tube using an MPD Mitamura Riken Kogyo (Japan) electrothermal melting point apparatus and are uncorrected. IR spectra in the range 4000-400 cm -1 were obtained on a Bruker-Vector FTIR spectrophotometer, with samples investigated as thin film from CDCl3 solution. 1 H NMR spectra were recorded on a Bruker-Avance-300 spectrometer, operating at 300 MHz. Mass spectra were recorded on a TOF LCT Premier (WATERS) Spectrometer coupled to an HPLC Alliance 2695 chain.
3. Synthesis and characterization of the compounds 3.1. Synthesis and characterization of N,N'-bis(phenylmethylene)hexane-1,6-diamine Benzaldehyde (0.4mmol) and hexane-1,6-diamine (0.2mmol) were dissolved in ether (30 ml). At room temperature, the mixture was stirred for three days to give a white milky precipitate. 
Antifungal testing Pathogenic strains of Candida albicans and Candida glabatawere obtained from National Laboratory of Public Health of Cote D'Ivoire and the Microbiology Laboratory of Swiss Scientific Research
Center in Cote D'Ivoire. Schiff bases were stored dry at room temperature and dissolved 1500μg/ml in dimethylsulfoxide (DMSO). Antifungal activities of each compound were evaluated by the agar disc-diffusion method. Sabarod's agar media (15 cm 3 ) kept at 45 o C was poured in the Petri-dishes and allowed to solidify. Sterile, filter paper discs of 10mm diameter were impregnated with prepared Schiff bases (50µl) and were placed on to the media, seeded with fungus. The plates were then incubated at 37 o C for 1-3 days. At the end of period the inhibition zones formed on media were measured with a zone reader in millimeters.
Results and Discussion
Four symmetric Schiff bases have been synthesized from the condensation reaction of 1,6-diaminohexane with benzaldehyde, and ortho, meta or para NO 2 -substituted benzaldehyde.The results of the antibacterial screening of compounds1b, 1c, and1d at a concentration of 1500 μg/ml against Staphylococcus aureus (CIP) 4.83 and Staphylococcus aureus sensitive to penicillinhave been found. The inhibition zones were measured in mm and results are shown in Table 1 .The inhibition zones diameters were between 10 and 16 mm. The results indicated that, this compounds showed significant activity against Staphylococcus aureus(CIP) 4.83 than Staphylococcus aureus sensitive to penicillin, while they were found to be inactive against Escherichia coli(CIP) 54127AF, Pseudomonas aeruginosa (CIP) 103467,Staphylococcus aureus ATTC 25923.Antibacterial activity of these compounds showed ascending order. When we increased concentration, area of inhibited growth also increased. We noted that compound 1a without nitro group was inactive on all the strains. On the strain Staphylococcus aureus(CIP), the compound 1cwas the most active with a MIC of 187.5μg/ml, and the compounds 1b and 1dthe least active with a MIC of 375μg/ml, whereas on the strain Staphylococcus aureus sensible, only compound1c has activity with a MIC value greater than 1500μg/ml. All synthesized compounds show no antifungal activity even at 1500μg/ml against C. albicans, as shown in Table 2 .However, on C.glabrata, all compounds showed activities with inhibition diameters between 10 and 11 mm. Compound 1a has a minimum inhibition concentration greater than 1500μg/ml, on the other hand for compounds 1b, 1c, 1dthe MIC value was1500μg/ml . 1b, 1c, 1d) showed activity with minimal inhibition concentrations of 1500μg/ml. The presence of the nitro group on the various benzene rings seems to be decisive for the manifestation of an important activity of these compounds.
TABLE2: Measurement of inhibition diameters and value of minimum inhibition concentration (MIC) for antifungal activity

